Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy.

Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Abstract Text:

    douglas l mannDouglas L Mann,michael a ackerMichael A Acker,mariell jessupMariell Jessup,hani n sabbahHani N Sabbah,randall c starlingRandall C Starling,spencer h kuboSpencer H Kubo, ,douglas l mannDouglas L Mann,michael a ackerMichael A Acker,mariell jessupMariell Jessup,hani n sabbahHani N Sabbah,randall c starlingRandall C Starling,spencer h kuboSpencer H Kubo, ,

    BACKGROUND: Left ventricular (LV) remodeling is related to adverse outcomes in heart failure. The CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, MN) is an implantable device that attenuates LV remodeling. METHODS: The Acorn trial assessed the safety and efficacy of the CSD in 300 heart failure patients. Patients needing mitral surgery (n = 193) were randomized to mitral surgery alone or mitral surgery plus CSD. Patients who did not need mitral surgery (n = 107) were randomized to medical therapy or medical therapy plus CSD. The primary endpoint was a clinical composite based on changes in patient vital status, the need for major cardiac procedures for worsening heart failure, and a change in New York Heart Association (NYHA) class. RESULTS: The proportional odds ratio for the primary endpoint favored treatment with the CSD (1.73 confidence interval [CI]: 1.07 to 2.79; p = 0.024). The CSD-treated patients received significantly (p = 0.01) fewer cardiac procedures indicative of worsening heart failure and had an improvement in New York Heart Association class (p = 0.049). There was no significant difference in survival between groups (p = 0.85). Treatment with the CSD led to a decrease in LV end-diastolic (p = 0.009) and end-systolic volumes (p = 0.017), an increase in the LV sphericity index (p = 0.026), an improvement in the Minnesota Living with Heart Failure score (p = 0.04), and the Short Form-36 Questionnaire (p = 0.015). There was no evidence for a significant difference (p = 0.43) in serious adverse events between the treatment and control groups. CONCLUSIONS: The results of the Acorn trial support the hypothesis that preventing LV remodeling with a CSD favorably impacts the untoward natural history of heart failure.

    Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Publishing Authors By Initials

    dl mannDL Mann,ma ackerMA Acker,m jessupM Jessup,hn sabbahHN Sabbah,rc starlingRC Starling,sh kuboSH Kubo, ,dl mannDL Mann,ma ackerMA Acker,m jessupM Jessup,hn sabbahHN Sabbah,rc starlingRC Starling,sh kuboSH Kubo, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Annals of thoracic surgery

    VOLUME: 84

    Page Numbers: 1226-35

    Journal Abbreviation: Ann. Thorac. Surg.

    ISSN: 1552-6259

    DAY: 24

    MONTH: Oct

    YEAR: 2007

    Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 15030100

    Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy.

    AFFILIATION: Baylor College of Medicine, Houston, Texas, USA. dmann@bcm.tmc.edu

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Thorac Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News